SELECT MEDICAL HOLDINGS CORPSEMEarnings & Financial Report
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
SEM Q1 FY2026 Key Financial Metrics
Revenue
$1.4B
Gross Profit
N/A
Operating Profit
$98.4M
Net Profit
$63.8M
Gross Margin
N/A
Operating Margin
6.9%
Net Margin
4.5%
YoY Growth
5.0%
EPS
$0.35
SELECT MEDICAL HOLDINGS CORP Q1 FY2026 Financial Summary
SELECT MEDICAL HOLDINGS CORP reported revenue of $1.4B (up 5.0% YoY) for Q1 FY2026, with a net profit of $63.8M (down 14.7% YoY) (4.5% margin).
Key Financial Metrics
| Total Revenue | $1.4B |
|---|---|
| Net Profit | $63.8M |
| Gross Margin | N/A |
| Operating Margin | 6.9% |
| Report Period | Q1 FY2026 |
SELECT MEDICAL HOLDINGS CORP Annual Revenue by Year
SELECT MEDICAL HOLDINGS CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.5B).
SELECT MEDICAL HOLDINGS CORP Quarterly Revenue & Net Profit History
SELECT MEDICAL HOLDINGS CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.4B | +5.0% | $63.8M | 4.5% |
| Q4 FY2025 | $1.4B | +6.4% | $20.2M | 1.4% |
| Q3 FY2025 | $1.4B | +7.2% | $28.8M | 2.1% |
| Q2 FY2025 | $1.3B | +4.5% | $40.6M | 3.0% |
| Q1 FY2025 | $1.4B | +2.4% | $56.7M | 4.2% |
| Q4 FY2024 | $1.3B | +7.8% | $-16.1M | -1.2% |
| Q3 FY2024 | $1.3B | +6.7% | $55.6M | 4.4% |
| Q2 FY2024 | $1.3B | +6.2% | $77.6M | 6.1% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.28B | $1.27B | $1.31B | $1.35B | $1.34B | $1.36B | $1.40B | $1.42B |
| YoY Growth | 6.2% | 6.7% | 7.8% | 2.4% | 4.5% | 7.2% | 6.4% | 5.0% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $7.88B | $8.00B | $5.61B | $5.70B | $5.74B | $5.69B | $5.85B | $6.04B |
| Liabilities | $6.14B | $5.70B | $3.61B | $3.65B | $3.74B | $3.67B | $3.82B | $3.94B |
| Equity | $1.42B | $1.92B | $1.68B | $1.72B | $1.67B | $1.69B | $1.71B | $2.08B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $278.2M | $181.0M | $125.4M | $-3.5M | $110.3M | $175.3M | $64.3M |